Clinical Trials Directory

Trials / Completed

CompletedNCT00976274

Korean Red Ginseng and Metabolic Syndrome

Effects of Korean Red Ginseng on Cardiovascular Risks in Subjects With Metabolic Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
The Korean Society of Ginseng · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Five factor consisting of Metabolic syndrome is closely linked by insulin resistance. Until now, several studies have been performed about effects of Korea red ginseng on hypertension, diabetes, and hyperlipidemia, but not metabolic syndrome. The investigators hypothesize that Korean red ginseng could improve each constituents of metabolic syndrome, arterial stiffness, and inflammatory markers. The aim of this study is to determine effects of Korean red ginseng on cardiovascular risks in subjects with metabolic syndrome.

Detailed description

The details of study objective are followed by these: * comparison of blood pressure before and after Korean red ginseng administration * comparison of metabolic indicator before and after Korean red ginseng administration * comparison of oxidative stress and inflammatory markers before and after Korean red ginseng administration * comparison of arterial stiffness before and after Korean red ginseng administration

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTKorean red ginseng5 capsules (300 mg/capsule) three times everyday for 12 weeks
DIETARY_SUPPLEMENTstarch5 capsules three times everyday for 12 weeks

Timeline

Start date
2009-08-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2009-09-14
Last updated
2012-02-27
Results posted
2012-02-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT00976274. Inclusion in this directory is not an endorsement.